DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI
(Financial Post, 2025-11-13T21:16:54Z)